These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 38159821)
1. Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma. Yang J; Qin L; Zhou S; Li J; Tu Y; Mo M; Liu X; Huang J; Qin X; Jiao A; Wei W; Yang P J Ethnopharmacol; 2024 Apr; 323():117667. PubMed ID: 38159821 [TBL] [Abstract][Full Text] [Related]
2. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts. Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682 [TBL] [Abstract][Full Text] [Related]
3. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mTOR pathway. Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211 [TBL] [Abstract][Full Text] [Related]
5. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway. ShuoWang ; Song Z; Gong X; Ou C; Zhang W; Wang J; Yao C; Qin S; Yan B; Li Q; Wei K; Hou X; Zhou X; Miao J J Ethnopharmacol; 2021 May; 271():113879. PubMed ID: 33524509 [TBL] [Abstract][Full Text] [Related]
6. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway. Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742 [TBL] [Abstract][Full Text] [Related]
7. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway. Guo S; Zhang J; Wei C; Lu Z; Cai R; Pan D; Zhang H; Liang B; Zhang Z Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143 [TBL] [Abstract][Full Text] [Related]
8. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling. Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612 [TBL] [Abstract][Full Text] [Related]
9. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies. Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505 [TBL] [Abstract][Full Text] [Related]
10. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway. Xie Z; Li W; Ai J; Xie J; Zhang X J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661 [TBL] [Abstract][Full Text] [Related]
11. Unraveling the mechanism of Yiqi Jiedu formula against nasopharyngeal carcinoma: An investigation integrating network pharmacology, serum pharmacochemistry, and metabolomics. Zhou F; Wang W; Xu R; Liu L; Lin T; He L; Tang L; Wang X; He Y J Ethnopharmacol; 2024 Jan; 319(Pt 3):117343. PubMed ID: 37879509 [TBL] [Abstract][Full Text] [Related]
12. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma. Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308 [TBL] [Abstract][Full Text] [Related]
13. The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma. Xiong W; Li D; Ao F; Tu Z; Xiong J Cell Biochem Funct; 2024 Mar; 42(2):e3939. PubMed ID: 38454810 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway. Liu H; Li X; Duan Y; Xie JB; Piao XL J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477 [TBL] [Abstract][Full Text] [Related]
15. RNA-binding domain 2 of nucleolin is important for the autophagy induction of curcumol in nasopharyngeal carcinoma cells. Liu G; Wang J; Han M; Li X; Zhou L; Dou T; Liu Y; HuangFu M; Guan X; Wang Y; Tang W; Liu Z; Li L; Ding H; Chen X Phytomedicine; 2023 Jul; 115():154833. PubMed ID: 37137203 [TBL] [Abstract][Full Text] [Related]
16. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling. Huang W; Zeng C; Liu J; Yuan L; Liu W; Wang L; Zhu H; Xu Y; Luo Y; Xie D; Jiang X; Ren C Biochem Biophys Res Commun; 2019 Jun; 514(1):64-70. PubMed ID: 31023529 [TBL] [Abstract][Full Text] [Related]
17. Integration of network pharmacology and serum medicinal chemistry to investigate the pharmacological mechanisms of QiZhuYangGan Decoction in the treatment of hepatic fibrosis. Deng JW; Yuan S; Shi LP; Chen X; Liu J; Chen ZW; Tan KY; Yang Q; Cao WF J Ethnopharmacol; 2024 Apr; 323():117730. PubMed ID: 38190954 [TBL] [Abstract][Full Text] [Related]
18. Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking. Fan JY; Liu J; Zhang WQ; Lin T; Hu XR; Zhou FL; Tang L; He YC; Shi HJ Medicine (Baltimore); 2023 Dec; 102(48):e36477. PubMed ID: 38050231 [TBL] [Abstract][Full Text] [Related]
19. Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma. Su C; Li M; Yang Y; Wang Z; Wang Q; Wang W; Ma X; Jie R; Chen H; Li X; Lu J Anticancer Agents Med Chem; 2023; 23(17):1944-1957. PubMed ID: 37497684 [TBL] [Abstract][Full Text] [Related]
20. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma. Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]